-Tadeusz Wisniewski Researcher Activity Profile

Research Author Detailed Information 

Tadeusz Wisniewski Publication Rate By Year

Tadeusz Wisniewski has published 1 paper(s) in 2002, 1 paper(s) in 2006, 9 paper(s) in 2007, 2 paper(s) in 2008, for a total of 13 research publications in total.

Tadeusz T Wisniewski Author Information

LAST NAME: wisniewski

FIRST NAME: Tadeusz

INITIALS: t

AFFILIATION:

Papers

Tadeusz Wisniewski's Publication Record

1. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. Year Published: 2002
Department of Orthopaedics, 4th Floor, University of Natal, 719 Umbilo road, Durban, South Africa.
2. Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease. Year Published: 2006
Department of Neurology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA. sadowm01@med.nyu.edu
3. Test for detection of disease-associated prion aggregate in the blood of infected but asymptomatic animals. Year Published: 2007
Institute of Pathology School of Medicine, Case Western Reserve University, Cleveland, Ohio 44107-1712, USA.
4. CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils. Year Published: 2007
New York State Institute for Basic Research in Development Disabilities, 1050 Forest Hill Rd., Staten Island, NY 10314, USA. darylspinner@aol.com
5. Ligand binding and calcium influx induce distinct ectodomain/gamma-secretase-processing pathways of EphB2 receptor. Year Published: 2007
Department of Psychiatry and Neuroscience, Mount Sinai School of Medicine New York University, New York, NY 10029, USA, and Institute for Molecular Cardiovascular Research, University Hospital Reinisch-West Faelische Technische Hochschule, Aachen, Germany
6. Disease modifying approaches for Alzheimer's pathology. Year Published: 2007
Department of Neurology, New York University School of Medicine, New York, NY 10016, USA.
7. Is vaccination against transmissible spongiform encephalopathy feasible? Year Published: 2007
Department of Psychiatry, New York University School of Medicine, 560 First Avenue, New York, NY 10016, USA. thomas.wisniewski@med.nyu.edu
8. Therapeutic approaches for prion and Alzheimer's diseases. Year Published: 2007
Department of Neurology, New York University School of Medicine, NY 10016, USA. thomas.wisniewski@med.nyu.edu
9. Mechanistic insights into the cure of prion disease by novel antiprion compounds. Year Published: 2007
Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom.
10. Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques. Year Published: 2007
Department of Chemistry, New York University, School of Medicine, New York, NY 11219, USA.
11. Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques. Year Published: 2007
Department of Chemistry, New York University, School of Medicine, New York, NY 11219, USA.
12. 5-Lipoxygenase gene disruption reduces amyloid-{beta} pathology in a mouse model of Alzheimer's disease. Year Published: 2008
Dept. of Pharmacology, Temple University, 3420 North Broad St., Medical Research Bldg., Room 706A, Philadelphia, PA 19140, USA. praticod@temple.edu.
13. 5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease. Year Published: 2008
Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140, USA.